Morgan Stanley raises Moderna price target to $89, keeps Equal Weight
Morgan Stanley raises its price target on Moderna to $89 from $39 and maintains an Equal Weight rating.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.